Feasibility of Semaglutide in Advanced Lung Disease
Feasibility of Semaglutide in Advanced Lung Disease
Recruiting · NCT05746039 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Feasibility of Semaglutide in Advanced Lung Disease | Body Weight, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, chronic obstructive pulmonary disease, hypertensive disorder, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, nutritional disorder, obesity disorder, obstructive lung disease, overnutrition, pulmonary hypertension, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-21 | NCT05746039 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Pennsylvania Perelman School of Medicine | Philadelphia | United States | 10 |